Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652.

Ichimiya T, Suhara T, Sudo Y, Okubo Y, Nakayama K, Nankai M, Inoue M, Yasuno F, Takano A, Maeda J, Shibuya H.

Biol Psychiatry. 2002 May 1;51(9):715-22.

PMID:
11983185
2.

Age-related decline of serotonin transporters in living human brain of healthy males.

Yamamoto M, Suhara T, Okubo Y, Ichimiya T, Sudo Y, Inoue M, Takano A, Yasuno F, Yoshikawa K, Tanada S.

Life Sci. 2002 Jul 5;71(7):751-7.

PMID:
12074934
3.

Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.

Cannon DM, Ichise M, Rollis D, Klaver JM, Gandhi SK, Charney DS, Manji HK, Drevets WC.

Biol Psychiatry. 2007 Oct 15;62(8):870-7. Epub 2007 Aug 2.

PMID:
17678634
4.

Quantitative analysis for estimating binding potential of the brain serotonin transporter with [11 C]McN5652.

Ikoma Y, Suhara T, Toyama H, Ichimiya T, Takano A, Sudo Y, Inoue M, Yasuno F, Suzuki K.

J Cereb Blood Flow Metab. 2002 Apr;22(4):490-501.

PMID:
11919520
5.

No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET.

Shioe K, Ichimiya T, Suhara T, Takano A, Sudo Y, Yasuno F, Hirano M, Shinohara M, Kagami M, Okubo Y, Nankai M, Kanba S.

Synapse. 2003 Jun 15;48(4):184-8.

PMID:
12687637
6.

Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652.

Szabo Z, Kao PF, Scheffel U, Suehiro M, Mathews WB, Ravert HT, Musachio JL, Marenco S, Kim SE, Ricaurte GA, et al.

Synapse. 1995 May;20(1):37-43.

PMID:
7624828
7.

In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652.

Parsey RV, Kegeles LS, Hwang DR, Simpson N, Abi-Dargham A, Mawlawi O, Slifstein M, Van Heertum RL, Mann JJ, Laruelle M.

J Nucl Med. 2000 Sep;41(9):1465-77. Erratum in: J Nucl Med 2000 Dec;41(12):1946.

8.

Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.

Meyer JH, Houle S, Sagrati S, Carella A, Hussey DF, Ginovart N, Goulding V, Kennedy J, Wilson AA.

Arch Gen Psychiatry. 2004 Dec;61(12):1271-9.

PMID:
15583118
9.

High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography.

Suhara T, Takano A, Sudo Y, Ichimiya T, Inoue M, Yasuno F, Ikoma Y, Okubo Y.

Arch Gen Psychiatry. 2003 Apr;60(4):386-91.

PMID:
12695316
10.

Comparative evaluation of two serotonin transporter ligands in the human brain: [(11)C](+)McN5652 and [(11)C]cyanoimipramine.

Takano A, Suhara T, Sudo Y, Inoue M, Hashimoto K, Zhang MR, Ichimiya T, Yasuno F, Suzuki K.

Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1289-97. Epub 2002 Jul 27.

PMID:
12271409
11.

A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.

Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M.

Am J Psychiatry. 2004 Jul;161(7):1181-9.

PMID:
15229049
12.

Positron emission tomography imaging of the serotonin transporter in the pig brain using [11C](+)-McN5652 and S-([18F]fluoromethyl)-(+)-McN5652.

Brust P, Zessin J, Kuwabara H, Pawelke B, Kretzschmar M, Hinz R, Bergman J, Eskola O, Solin O, Steinbach J, Johannsen B.

Synapse. 2003 Feb;47(2):143-51.

PMID:
12454952
13.

Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET.

Buchert R, Thomasius R, Nebeling B, Petersen K, Obrocki J, Jenicke L, Wilke F, Wartberg L, Zapletalova P, Clausen M.

J Nucl Med. 2003 Mar;44(3):375-84.

14.

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.

Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Küfferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, Brücke T.

World J Biol Psychiatry. 2002 Jul;3(3):133-46. Review.

PMID:
12478878
16.

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

Meyer JH, Wilson AA, Sagrati S, Hussey D, Carella A, Potter WZ, Ginovart N, Spencer EP, Cheok A, Houle S.

Am J Psychiatry. 2004 May;161(5):826-35.

PMID:
15121647
17.

Positron emission tomography of 5-HT transporter sites in the baboon brain with [11C]McN5652.

Szabo Z, Scheffel U, Suehiro M, Dannals RF, Kim SE, Ravert HT, Ricaurte GA, Wagner HN Jr.

J Cereb Blood Flow Metab. 1995 Sep;15(5):798-805.

PMID:
7673372
18.

Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.

Miller JM, Oquendo MA, Ogden RT, Mann JJ, Parsey RV.

J Psychiatr Res. 2008 Oct;42(14):1137-44. doi: 10.1016/j.jpsychires.2008.01.012. Epub 2008 Mar 10.

19.

Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652.

Simpson HB, Lombardo I, Slifstein M, Huang HY, Hwang DR, Abi-Dargham A, Liebowitz MR, Laruelle M.

Biol Psychiatry. 2003 Dec 15;54(12):1414-21.

PMID:
14675806
20.

Kinetic analysis of [11C]McN5652: a serotonin transporter radioligand.

Szabo Z, Scheffel U, Mathews WB, Ravert HT, Szabo K, Kraut M, Palmon S, Ricaurte GA, Dannals RF.

J Cereb Blood Flow Metab. 1999 Sep;19(9):967-81.

Supplemental Content

Support Center